Myasthenia Gravis Induced by Ipilimumab in a Patient With Metastatic Melanoma
Sign Up to like & getrecommendations! Published in 2018 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2018.00150
Abstract: In daily clinical practice, there is a growing number of patients receiving new biological agents used in the treatment of malignancies. Ipilimumab is a fully humanized monoclonal antibody approved for patients with melanoma. It acts… read more here.
Keywords: gravis; induced ipilimumab; ipilimumab patient; gravis induced ... See more keywords